Drug Trial Radar · NCT00849108
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
Last checked: Nov 20, 2026Latest source record: Oct 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
176
Actual
Start
Jan 2009
Primary completion
Jun 2010
Study completion Jun 2010
Sponsor
- Lead sponsor
- Lantheus Medical ImagingIndustry
- Sponsor type
- Industry
- First posted
- Feb 23, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to get more information on using BMS747158 (the study drug),a drug with small amounts of radioactivity to allow for heart imaging, during a PET scan which can then be compared to other images such as SPECT. The safety and quality of images will be studied.
Conditions
- Ischemia
Interventions
BMS747158Drug
dosages at rest and at stress were not to exceed a total of 14 mCi. Cohort 1: Patients received either 2 or 3 IV bolus injections of BMS747158: 1 at rest and 1 or 2 during stress, over a 1-day or 2-day period. Cohort 2: Patients to recieve IV bolus injections of BMS747158: For the Pharmacologic (Adenosine) Stress: * Doses at rest were to range between 2.9 and 3.4 mCi. * Doses under stress were to be a factor of 2.0 to 2.4 greater than the rest dose, resulting in a range of stress doses between 5.8 and 8.2 mCi. For the Exercise Stress: * Doses at rest were to range between 1.7 and 2.0 mCi. * Doses under stress were to be a factor of 3.0 to 3.6 greater than the rest dose, resulting in a range between 5.1 and 7.2 mCi.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Determination of Rest Dose: Dose Acquistion Time ProductTime frame: Dosing visit
- Cohort 2: Diagnostic Efficacy of One-day Rest/Stress BMS747158 PET MPI Sensitivity (SN) vs SPECT MPI SensitivityTime frame: Dosing visit
- Cohort 1: Determination of Ratio of Stress Dose to Rest DoseTime frame: Dosing visit
- Cohort 2: Diagnostic Efficacy of One-day Rest/Stress BMS747158 PET MPI Specificity (SP) vs SPECT MPI SpecificityTime frame: Dosing Visit
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Silicon Valley Medical Imaging
Fremont, California
Scripps Memorial Hospital
La Jolla, California
Cedars-Sinai Medical Center
Los Angeles, California
UCLA Medical Plaza
Los Angeles, California
Radiological Associates of Sacramento
Sacramento, California
VA Healthcare System San Diego
San Diego, California
Hartford Hospital
Hartford, Connecticut
Yale University
New Haven, Connecticut
Emory University Hospital
Atlanta, Georgia
Primary Care Cardiology Research, Inc
Ayer, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Brigham & Women's Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Cardiovascular Consultants
Kansas City, Missouri
Saint Louis University
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
University of Medicine and Dentistry of New Jersey
Newark, New Jersey
Holy Name Hospital
Teaneck, New Jersey
Columbia University Medical Center
New York, New York
St. Francis Hospital
Roslyn, New York
University Hospital Case Medical Center
Cleveland, Ohio
Midwest Cardiology Research Foundation
Columbus, Ohio
Mountain States Health Alliance
Johnson City, Tennessee
East Tennessee Clinical Research Institute
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.